TCRT   $0.5162  3.48% Market Closed

Alaunos Therapeutics Inc
Total Cash 2.46M
totalCashPerShare 1.538
EBITDA -12.58M
Total Debt 0.00
quickRatio 2.72
currentRatio 5.158
Total Revenue 7.00K
debtToEquity
Revenue/Share 0.004
ROA -0.51764
ROE -1.50498
grossProfits
freeCashflow -11.83M
operatingCashflow -17.36M
earningsGrowth
revenueGrowth 0.0
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -291.5
profitMargins 0.0
enterpriseValue 1.40M
forwardPE
floatShares 1.31M
sharesOutstanding 1.60M
sharesShort 130.69K
sharesShortPriorMonth 139.65K
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.14%
heldPercentInstitutions 0.15%
Short Ratio help_outline 4.84%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 2.355
Price To Book help_outline 1.02
earningsQuarterlyGrowth
netIncomeToCommon -19.13M
trailingEps -319.97%
forwardEps -0.60%
enterpriseToEbitda -0.11
lastDividendValue
lastDividendDate
currentQuarterEstimate 1Q 2024
institutionsCount 55
lastUpdated Oct. 17, 2024, 4:09 a.m.